Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration
- 29 July 2005
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 333 (2), 544-549
- https://doi.org/10.1016/j.bbrc.2005.05.150
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Ubiquitin–proteasome system and Parkinson's diseasesExperimental Neurology, 2005
- Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's diseaseAnnals of Neurology, 2004
- Neurodegenerative diseases and oxidative stressNature Reviews Drug Discovery, 2004
- Proteasome inhibition causes nigral degeneration with inclusion bodies in ratsNeuroReport, 2002
- Aggregation and neurotoxicity of α-synuclein and related peptidesBiochemical Society Transactions, 2002
- Book Review: Iron and Parkinson’s DiseaseThe Neuroscientist, 2002
- Metal-triggered Structural Transformations, Aggregation, and Fibrillation of Human α-SynucleinPublished by Elsevier BV ,2001
- Ca2+ Binding to α-Synuclein Regulates Ligand Binding and OligomerizationPublished by Elsevier BV ,2001
- Role of Cytochrome c as a Stimulator of α-Synuclein Aggregation in Lewy Body DiseasePublished by Elsevier BV ,1999
- The Role of Iron in NeurodegenerationDrugs & Aging, 1999